Have your own idea? Try our Stock Screener
Tunisian (TUNINDEX) Healthcare Sector Analysis
UpdatedMay 21, 2026
DataAggregated Company Financials
Companies2
- 7D4.4%
- 3M-0.4%
- 1Y19.9%
- YTD-1.1%
Over the last 7 days, the Healthcare industry has risen 3.6%, driven by gains from every company within the industry. This takes the industry's 12 month performance to a gain of 21%. Looking forward, earnings are expected to remain mostly flat in the next few years.
Sector Valuation and Performance
Has the Tunisian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 May 2026 | د.ت304.5m | د.ت153.8m | د.ت22.2m | 13.3x | 13.7x | 2x |
| Sat, 18 Apr 2026 | د.ت297.7m | د.ت153.8m | د.ت22.2m | 13x | 13.4x | 1.9x |
| Mon, 16 Mar 2026 | د.ت290.3m | د.ت153.8m | د.ت22.2m | 12.7x | 13.1x | 1.9x |
| Wed, 11 Feb 2026 | د.ت303.4m | د.ت153.8m | د.ت22.2m | 13.4x | 13.7x | 2x |
| Fri, 09 Jan 2026 | د.ت314.6m | د.ت153.8m | د.ت22.2m | 13.9x | 14.2x | 2x |
| Sun, 07 Dec 2025 | د.ت289.8m | د.ت153.8m | د.ت22.2m | 12.7x | 13x | 1.9x |
| Tue, 04 Nov 2025 | د.ت266.7m | د.ت153.8m | د.ت22.2m | 11.7x | 12x | 1.7x |
| Thu, 02 Oct 2025 | د.ت282.4m | د.ت153.8m | د.ت22.2m | 12.4x | 12.7x | 1.8x |
| Sat, 30 Aug 2025 | د.ت287.4m | د.ت147.7m | د.ت19.4m | 14.4x | 14.8x | 1.9x |
| Mon, 28 Jul 2025 | د.ت303.6m | د.ت147.7m | د.ت19.4m | 15.3x | 15.7x | 2.1x |
| Wed, 25 Jun 2025 | د.ت267.2m | د.ت141.0m | د.ت6.4m | 40.2x | 41.5x | 1.9x |
| Fri, 23 May 2025 | د.ت253.3m | د.ت141.1m | د.ت6.4m | 37.8x | 39.4x | 1.8x |
| Sun, 20 Apr 2025 | د.ت246.7m | د.ت141.1m | د.ت6.4m | 36.6x | 38.4x | 1.7x |
| Tue, 18 Mar 2025 | د.ت243.6m | د.ت141.1m | د.ت6.4m | 36.6x | 37.9x | 1.7x |
| Thu, 13 Feb 2025 | د.ت230.1m | د.ت141.1m | د.ت6.4m | 34.8x | 35.8x | 1.6x |
| Sat, 11 Jan 2025 | د.ت230.5m | د.ت141.1m | د.ت6.4m | 34.8x | 35.8x | 1.6x |
| Mon, 09 Dec 2024 | د.ت240.9m | د.ت141.1m | د.ت6.4m | 36x | 37.4x | 1.7x |
| Wed, 06 Nov 2024 | د.ت240.3m | د.ت141.1m | د.ت6.4m | 35.8x | 37.4x | 1.7x |
| Fri, 04 Oct 2024 | د.ت242.3m | د.ت141.1m | د.ت6.4m | 36.1x | 37.7x | 1.7x |
| Sun, 01 Sep 2024 | د.ت241.0m | د.ت136.0m | د.ت5.5m | 41.5x | 43.5x | 1.8x |
| Tue, 30 Jul 2024 | د.ت233.5m | د.ت136.0m | د.ت5.5m | 40.8x | 42.1x | 1.7x |
| Thu, 27 Jun 2024 | د.ت215.0m | د.ت136.0m | د.ت5.5m | 37.4x | 38.8x | 1.6x |
| Sat, 25 May 2024 | د.ت233.3m | د.ت115.1m | د.ت13.1m | 17.4x | 17.8x | 2x |
| Mon, 22 Apr 2024 | د.ت237.1m | د.ت115.1m | د.ت13.1m | 17.5x | 18.1x | 2.1x |
| Wed, 20 Mar 2024 | د.ت235.9m | د.ت115.1m | د.ت13.1m | 17.5x | 18x | 2x |
| Fri, 16 Feb 2024 | د.ت235.2m | د.ت115.1m | د.ت13.1m | 17.4x | 17.9x | 2x |
| Sun, 14 Jan 2024 | د.ت362.7m | د.ت223.6m | د.ت13.6m | 136.5x | 26.6x | 1.6x |
| Tue, 12 Dec 2023 | د.ت360.8m | د.ت223.6m | د.ت13.6m | 136.3x | 26.5x | 1.6x |
| Thu, 09 Nov 2023 | د.ت388.3m | د.ت223.6m | د.ت13.6m | 137.3x | 28.5x | 1.7x |
| Sat, 07 Oct 2023 | د.ت392.2m | د.ت223.6m | د.ت13.6m | 137.4x | 28.8x | 1.8x |
| Mon, 04 Sep 2023 | د.ت382.3m | د.ت204.8m | د.ت8.3m | 143.4x | 45.9x | 1.9x |
| Wed, 02 Aug 2023 | د.ت391.5m | د.ت204.8m | د.ت8.3m | 144x | 47x | 1.9x |
| Fri, 30 Jun 2023 | د.ت389.9m | د.ت204.8m | د.ت8.3m | 143.9x | 46.8x | 1.9x |
| Sun, 28 May 2023 | د.ت371.8m | د.ت205.0m | د.ت8.3m | 142.9x | 44.6x | 1.8x |
Price to Earnings Ratio
44.6x
Current Industry PE
- There are only 2 companies in the Tunisian Healthcare industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 39% per year over the last three years.
- Meanwhile revenues for these companies have declined 9.1% per year.
- This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.
Industry Trends
Which industries have driven the changes within the Tunisian Healthcare sector?
| TN Market | 1.45% | |
| Healthcare | 4.37% | |
| Pharma | 4.37% | |
Industry PE
- Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 28.8x.
- Analysts are expecting annual earnings growth of 0.9%, which is lower than the prior year's growth of 245.3% per year.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 28.8x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 0.9% over the next 5 years.
- In contrast, the Pharma industry is expected to see its earnings growth to stay flat over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| UMED Unité de Fabrication des Médicaments | د.ت9.25 | 4.2% +د.ت11.8m | 21.4% | PE13.3x | |
| SIPHA Société des Industries Pharmaceutiques de Tunisie - | د.ت4.70 | 12.2% +د.ت918.0k | -16.1% | n/a |